| Category | Min Lots | Shares | Amount |
|---|---|---|---|
| Retail (sNII) | 1 | 6,000 | ₹1,20,000 |
| HNI / NII | 2 | 12,000 | ₹2,40,000 |
| Category | Sub (×) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII / HNI (Total) | — | 11,88,000 (47.48%) | — | ₹237.60 Cr |
| Retail Investors | — | 11,88,000 (47.48%) | — | ₹237.60 Cr |
| Total ** | — | 25,02,000 (100.00%) | — | ₹5,004.00 Cr |
| Market Maker * | — | 1,26,000 (5.04%) | — | ₹2.52 Cr |
| Metric | 31 Mar 2013 | 31 Mar 2012 | 31 Mar 2011 |
|---|---|---|---|
| Revenue | 19.85 | 16.10 | 13.44 |
| PAT | 1.30 | 0.54 | 0.41 |
| EBITDA | — | — | — |
| Net Worth | — | — | — |
| Total Assets | 40.56 | 38.55 | 27.62 |
| Reserves | 7.51 | 4.93 | 2.79 |
| Borrowings | — | — | — |
Incorporated in December 2005, R J Biotech Ltd. is an agri-biotechnology company that focuses on developing proprietary hybrids with improved nutritional and economic characteristics. The company works with various crops, including fiber crops like cotton, cereal crops such as rice, maize, and pearl millet, and a variety of vegetable crops.
The company operates well-equipped research stations in Aurangabad and Hyderabad, staffed by experienced scientists and breeders.
These facilities enhance crop improvement, production, and marketing of hybrid seeds. R J Bio-Tech has released 31 field and 42 vegetable crop hybrids, establishing leadership in states for chili, tomato, okra, and watermelon hybrids.
The company runs processing plants with a total capacity of 45,000 metric tons per year and provides about 40,000 square feet of storage. Its network spans several Indian states, backed by 250-300 dealers, 300-350 distributors, and 1,000-1,500 sub-dealers focused on delivering quality seeds to farmers.
The company offers a wide range of hybrid seeds, including:
The company's strong distribution network comprises over 1,000 sub-dealers and distributors, making its products accessible to farmers nationwide.
As of March 2013, the company had 110 employees, with over 45% in sales and marketing and 18% in R&D activities, supporting expansion plans.